MZEI

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/23/2017
Contact Info
  • 4000 Bridgeway
  • Suite 401
  • Sausalito, CA 94965

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0000753772
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5122 - Drugs, proprietaries, and sundries
Incorporated In: NV, USA
Year of Inc. 1984
Employees 4 a/o Sep 24, 2014
Company Officers/Contacts
David A. Esposito Interim CEO
Stephanie Lynn Sorensen CFO
Jill Marshall Director, Ops.
Dr. Michael E. Shannon Medical Director, President
Company Directors
David A. Esposito Chairman, Independent Director, Audit Committee Member, Compensation Committee Member
Vincent C Caponi Independent Director, Audit Committee Member, Compensation Committee Member
Daniel Hoyt Independent Director, Audit Committee Member, Compensation Committee Member
Dr. Michael E. Shannon
Service Providers
Accounting/Auditing Firm
Tanner LLC
215 South State St.
Suite 800
Salt Lake City, UT, 84111
United States
 
Securities Counsel
Durham, Jones & Pinegar Law
111 East Broadway
Suite 900
Salt Lake City, UT, 84111
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Madison Funding, Inc. to 3-86
MZEI Security Details
Share Structure
Market Value1 $31,199,791 a/o Apr 28, 2017
Authorized Shares 395,000,000 a/o Sep 30, 2016
Outstanding Shares 394,934,068 a/o Mar 22, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 2,300 a/o Mar 22, 2017
Short Selling Data
Short Interest 20,570 (-1.37%)
Mar 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security